New partnership to advance precision medicine in lung cancer diagnosis More: Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials Source: News
read more
Partnership aims to advance Alzheimer’s research with innovative tools More: Actinogen boosts trial with Cambridge Cognition’s digital suite Source: News
read moreAfter a run of court victories in a patent dispute with the U.S. government, Gilead has agreed to settle to resolve the feds’ last-ditch appeal. Terms of the deal were not disclosed in the case, which involved the government’s patents
read moreKite Pharma is flying high with the addition of a new member to its senior leadership team. Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior VP and head of global commercial, he announced on LinkedIn this
read moreThe FDA has issued a complete response letter for Atara’s biologics license application “solely related to inspection findings” at a third-party manufacturer, the biotech said. More: Atara, Pierre Fabre hit a hurdle with Ebvallo in the US courtesy of manufacturing
read moreAileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. Now, the biotech has distanced itself from its premerger form by rebranding as Rein Therapeutics. More: Aileron straps in for
read more© 1994 - 2026 B.M. Pharmaceuticals